SCHEMBL6528658

SCHEMBL6528658

CS(=O)(=O)Nc1n[nH]c2c(F)c(Cl)c(-c3ccccc3)cc12.Cc1ccc(S(=O)(=O)Nc2n[nH]c3c(F)c(Cl)c(-c4ccccc4)cc23)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 3/20 0.54
CDK1 P06493 1/20 0.54
CDK2 P24941 1/20 0.54
GSK3A P49840 1/20 0.43
LMNA P02545 5/20 0.42
CA12 O43570 2/20 0.42
CA2 P00918 2/20 0.42
CA9 Q16790 2/20 0.42
MCOLN3 Q8TDD5 1/20 0.42
CKS1B P61024 1/20 0.40
SKP2 Q13309 1/20 0.40
MEN1 O00255 5/20 0.39
KMT2A Q03164 5/20 0.39
MAPT P10636 4/20 0.38
ACLY P53396 1/20 0.38
GAA P10253 2/20 0.38
TDP1 Q9NUW8 1/20 0.37
MAP2K4 P45985 2/20 0.37
CA1 P00915 1/20 0.37
ALDH1A1 P00352 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1374941 0.96 GSK3B (0.57) GSK3BCDK1CDK2LMNACA12
SCHEMBL1378973 0.90 GSK3B (0.64) GSK3BCDK1CDK2GSK3ALMNA
SCHEMBL1377458 0.89 GSK3B (0.60) GSK3BCDK1CDK2GSK3AACLY
SCHEMBL1379072 0.88 GSK3B (0.57) GSK3BCDK1CDK2MEN1KMT2A
SCHEMBL1379009 0.86 GSK3B (0.55) GSK3BCDK1CDK2MAPTGAA
SCHEMBL1378226 0.86 GSK3B (0.55) GSK3BCDK1CDK2CKS1BSKP2
SCHEMBL2334200 0.85 GSK3B (0.53) GSK3BCDK1CDK2CKS1BSKP2
SCHEMBL6532777 0.84 GSK3B (0.52) GSK3BCDK1CDK2CKS1BSKP2
SCHEMBL1379098 0.83 GSK3B (0.59) GSK3BCDK1CDK2LMNACKS1B
SCHEMBL6529436 0.83 GSK3B (0.52) GSK3BCDK1CDK2CKS1BSKP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1572200-A1 AMINOINDAZOLE DERIVATIVES AND USE THEREOF AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-09-14 EP disclosed
WO-2004062662-A1 AMINOINDAZOLE DERIVATIVES AND USE THEREOF AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-07-29 WO disclosed